Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(8):632-633; doi:10.1093/jnci/94.8.632
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nilsson, H.-O.
Right arrow Articles by Wadström, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nilsson, H.-O.
Right arrow Articles by Wadström, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 8, 632-633, April 17, 2002
© 2002 Oxford University Press


CORRESPONDENCE

Re: Helicobacter pylori Seropositivity as a Risk Factor for Pancreatic Cancer

Hans-Olof Nilsson, Unne Stenram, Ingemar Ihse, Torkel Wadström

Affiliations of authors: H.-O. Nilsson, T. Wadström (Department of Medical Microbiology, Dermatology and Infection), U. Stenram, (Department of Pathology), I. Ihse (Department of Surgery), Lund University, Lund, Sweden.

Correspondence to: Torkel Wadström, M.D., Ph.D., Dept. of Medical Microbiology, Dermatology and Infection, Lund University, Sölvegatan 23, SE-223 62 LUND, Sweden (e-mail: Torkel.Wadstrom@mmb.lu.se).

In the study of Helicobacter pylori seropositivity as a risk factor for pancreatic cancer, Stolzenberg-Solomon et al. (1) concluded that their findings support a possible role for the presence of H. pylori in the development of pancreatic cancer. We recently reported the identification of Helicobacter species in the livers of patients with hepatocellular carcinoma and cholangiocarcinoma (2) and in . . . [Full Text of this Article]

NOTES

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. de Martel, A. E. Llosa, G. D. Friedmana, J. H. Vogelman, N. Orentreich, R. Z. Stolzenberg-Solomon, and J. Parsonnet
Helicobacter pylori Infection and Development of Pancreatic Cancer
Cancer Epidemiol. Biomarkers Prev., May 1, 2008; 17(5): 1188 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
I. Nilsson, I. Kornilovs'ka, S. Lindgren, A. Ljungh, and T. Wadstrom
Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease
J. Med. Microbiol., November 1, 2003; 52(11): 949 - 953.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
H. A. Risch
Etiology of Pancreatic Cancer, With a Hypothesis Concerning the Role of N-Nitroso Compounds and Excess Gastric Acidity
J Natl Cancer Inst, July 2, 2003; 95(13): 948 - 960.
[Abstract] [Full Text] [PDF]